Third Rock Ventures IV, L.P., 10% Owner at Tango Therapeutics, Inc. (TNGX), sold 162,500 shares at $12.00 ($1.9M) on 2024-02-20, disclosed to the SEC on 2024-02-21.
Open-market sale of $1.9M TNGX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TNGX | SELL | 2024-07-26 | $3.9M | — | Filing → |
| TNGX | SELL | 2024-07-22 | $3.8M | — | Filing → |